Work

Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer

Year: 2014

Type: article

Source: Molecular Pharmaceutics

DOI: 10.1021/mp400687w

Authors: Huiyuan Wang, Feng Li, Chengan Du, Huixin Wang, Ram I. Mahato, Yongzhuo Huang

Institutions: Chinese Academy of Sciences, Shanghai Institute of Materia Medica, Hampton University, University of Nebraska Medical Center

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Key Research and Development Program of China

OpenAlex ID: W2329904271

FWCI: 2.568

Cites: 61

Cited by: 81

Related to: 10